XML 18 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities:    
Net income $ 1,688 $ 978
Adjustments to reconcile net income to net cash provided by operating activities:    
Deferred income taxes (13) 100
Depreciation and amortization 152 246
Non-cash operating lease cost 48 49
Amortization of capitalized software development costs and intellectual property licenses [1] 141 163
Share-based compensation expense [2] 138 127
Other 39 9
Changes in operating assets and liabilities:    
Accounts receivable, net 225 635
Software development and intellectual property licenses (300) (186)
Other assets (206) (48)
Deferred revenues (322) (809)
Accounts payable (71) 22
Accrued expenses and other liabilities (407) (373)
Net cash provided by operating activities 1,112 913
Cash flows from investing activities:    
Proceeds from maturities of available-for-sale investments 36 153
Purchases of available-for-sale investments (158) 0
Capital expenditures (56) (79)
Other investing activities 0 5
Net cash provided by (used in) investing activities (178) 79
Cash flows from financing activities:    
Proceeds from issuance of common stock to employees 114 87
Tax payment related to net share settlements on restricted stock units (41) (55)
Dividends paid (316) (283)
Proceeds from issuance of debt, net of discounts 1,994 0
Repayment of long-term debt (1,050) 0
Payment of financing costs (20) 0
Premium payment for early redemption of notes (28) 0
Net cash provided by (used in) financing activities 653 (251)
Effect of foreign exchange rate changes on cash and cash equivalents 32 (24)
Net increase in cash and cash equivalents and restricted cash 1,619 717
Cash and cash equivalents and restricted cash at beginning of period 5,798 4,229
Cash and cash equivalents and restricted cash at end of period $ 7,417 $ 4,946
[1] Excludes deferral and amortization of share-based compensation expense.
[2] Includes the net effects of capitalization, deferral, and amortization of share-based compensation expense.